Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Feb-24 5:00 PM View:  | Newamsterdam Pharma Co N.V. (NAMS) | 13-Feb-24 | Market Purchase | 5,000 | $19.00 | $95,000.00 | 25% 19.88K to 24.88K | 11% |
| 15-Jan-20 1:31 PM View: | Audentes Therapeutics, Inc. (BOLD) | 15-Jan-20 | Disposition (change in control) | 265,799 | $60.00 | $15,947,900.00 | (84%) 315.38K to 49.58K | |
| 15-Jan-20 1:31 PM View: | Audentes Therapeutics, Inc. (BOLD) | 15-Jan-20 | Disposition (change in control) | 49,576 | $60.00 | $2,974,560.00 | (100%) 49.58K to 0 | |
| 27-Dec-19 4:10 PM View: | Audentes Therapeutics, Inc. (BOLD) | 23-Dec-19 | Private Sale (Planned) | 10,000 | $59.60 | $595,993.00 | (3%) 326.38K to 316.38K | |
| 27-Dec-19 4:10 PM View: | Audentes Therapeutics, Inc. (BOLD) | 23-Dec-19 | Private Sale (Planned) | 1,000 | $59.60 | $59,596.30 | (< 1%) 316.38K to 315.38K | |
| 25-Sep-19 6:11 PM View: | Audentes Therapeutics, Inc. (BOLD) | 23-Sep-19 | Sale (Planned) | 10,000 | $32.16 | $321,616.00 | (3%) 337.38K to 327.38K | |
| 25-Sep-19 6:11 PM View: | Audentes Therapeutics, Inc. (BOLD) | 23-Sep-19 | Sale (Planned) | 1,000 | $32.18 | $32,182.00 | (< 1%) 327.38K to 326.38K | |
| 26-Jun-19 4:07 PM View: | Audentes Therapeutics, Inc. (BOLD) | 24-Jun-19 | Market Sale (Planned) | 20,000 | $37.77 | $755,413.00 | (6%) 358.38K to 338.38K | (2%) |
| 26-Jun-19 4:07 PM View: | Audentes Therapeutics, Inc. (BOLD) | 24-Jun-19 | Market Sale (Planned) | 1,000 | $38.20 | $38,200.80 | (< 1%) 338.38K to 337.38K | (< 1%) |
| 27-Mar-19 5:03 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Mar-19 | Market Sale (Planned) | 20,000 | $36.00 | $720,015.00 | (5%) 379.93K to 359.93K | (2%) |
| 27-Mar-19 5:03 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Mar-19 | Market Sale (Planned) | 1,558 | $35.98 | $56,058.40 | (< 1%) 359.93K to 358.38K | (2%) |
| 27-Dec-18 5:43 PM View: | Audentes Therapeutics, Inc. (BOLD) | 24-Dec-18 | Market Sale (Planned) | 20,000 | $18.67 | $373,434.00 | (5%) 411.93K to 391.93K | (32%) |
| 27-Dec-18 5:43 PM View: | Audentes Therapeutics, Inc. (BOLD) | 24-Dec-18 | Market Sale (Planned) | 12,000 | $18.53 | $222,365.00 | (3%) 391.93K to 379.93K | (33%) |
| 16-Nov-18 6:34 PM View: | Audentes Therapeutics, Inc. (BOLD) | 15-Nov-18 | Market Sale | 20,000 | $22.49 | $449,800.00 | (5%) 435.93K to 415.93K | (10%) |
| 16-Nov-18 6:34 PM View: | Audentes Therapeutics, Inc. (BOLD) | 15-Nov-18 | Market Sale | 4,000 | $22.49 | $89,960.00 | (< 1%) 415.93K to 411.93K | (10%) |
| 26-Sep-18 7:00 PM View: | Audentes Therapeutics, Inc. (BOLD) | 24-Sep-18 | Market Sale (Planned) | 20,000 | $37.35 | $747,061.00 | (4%) 468.93K to 448.93K | 34% |
| 26-Sep-18 7:00 PM View: | Audentes Therapeutics, Inc. (BOLD) | 24-Sep-18 | Market Sale (Planned) | 13,000 | $37.41 | $486,319.00 | (3%) 448.93K to 435.93K | 34% |
| 27-Jun-18 6:51 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jun-18 | Market Sale (Planned) | 20,000 | $40.42 | $808,344.00 | (4%) 504.59K to 484.59K | 39% |
| 27-Jun-18 6:51 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jun-18 | Market Sale (Planned) | 13,000 | $40.86 | $531,154.00 | (3%) 484.59K to 471.59K | 39% |
| 28-Mar-18 9:11 PM View: | Audentes Therapeutics, Inc. (BOLD) | 26-Mar-18 | Market Sale | 1,732 | $29.95 | $51,873.40 | (< 1%) 553.97K to 552.24K | 17% |
| 28-Mar-18 9:11 PM View: | Audentes Therapeutics, Inc. (BOLD) | 26-Mar-18 | Market Sale | 25,000 | $28.59 | $714,818.00 | (5%) 552.24K to 527.24K | 14% |
| 28-Mar-18 9:11 PM View: | Audentes Therapeutics, Inc. (BOLD) | 26-Mar-18 | Market Sale (Planned) | 18,268 | $29.21 | $533,591.00 | (3%) 527.24K to 508.97K | 15% |
| 28-Mar-18 9:11 PM View: | Audentes Therapeutics, Inc. (BOLD) | 26-Mar-18 | Market Sale (Planned) | 3,000 | $28.88 | $86,654.80 | (< 1%) 508.97K to 505.97K | 14% |
| 26-Dec-17 7:38 PM View: | Audentes Therapeutics, Inc. (BOLD) | 22-Dec-17 | Market Sale (Planned) | 15,000 | $30.88 | $463,160.00 | (3%) 567.93K to 552.93K | 20% |
| 26-Dec-17 7:38 PM View: | Audentes Therapeutics, Inc. (BOLD) | 22-Dec-17 | Market Sale (Planned) | 3,000 | $30.88 | $92,632.70 | (< 1%) 552.93K to 549.93K | 20% |
| 29-Sep-17 5:47 PM View: | Audentes Therapeutics, Inc. (BOLD) | 29-Sep-17 | Market Sale | 5,000 | $28.46 | $142,315.00 | (< 1%) 584.69K to 579.69K | 13% |
| 29-Sep-17 5:47 PM View: | Audentes Therapeutics, Inc. (BOLD) | 29-Sep-17 | Market Sale | 6,000 | $28.26 | $169,588.00 | (1%) 579.69K to 573.69K | 12% |
| 26-Sep-17 5:44 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Sep-17 | Market Sale (Planned) | 15,000 | $28.31 | $424,672.00 | (2%) 604.85K to 589.85K | 13% |
| 26-Sep-17 5:44 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Sep-17 | Market Sale (Planned) | 3,000 | $28.35 | $85,055.10 | (< 1%) 589.85K to 586.85K | 13% |
| 28-Jun-17 4:42 PM View: | Audentes Therapeutics, Inc. (BOLD) | 26-Jun-17 | Market Sale (Planned) | 15,000 | $19.78 | $296,682.00 | (2%) 611.93K to 596.93K | (25%) |
| 25-Jul-16 5:07 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Conversion | 9,000 | -- | -- | 2% 587.3K to 596.3K | |
| 25-Jul-16 5:07 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Conversion | 15,633 | -- | -- | 3% 596.3K to 611.93K | |
| 01-Jul-13 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion | 186,989 | -- | -- | 100% 0 to 186.99K | |
| 01-Jul-13 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Conversion | 14,314 | -- | -- | 8% 186.99K to 201.3K | |
| 01-Jul-13 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase | 3,500 | $14.00 | $49,000.00 | 2% 201.3K to 204.8K | |
| 01-Jul-13 4:38 PM View: | Esperion Therapeutics, Inc. (ESPR) | 01-Jul-13 | Purchase | 10,714 | $14.00 | $149,996.00 | 5% 204.8K to 215.52K | |
| 07-Jun-12 5:03 PM View: | Maxygen Inc. (MAXY) | 06-Jun-12 | Grant | 10,000 | -- | -- | 20% 50.0K to 60.0K | |
| 01-Jun-11 6:48 PM View: | Maxygen Inc. (MAXY) | 27-May-11 | Grant | 10,000 | -- | -- | 25% 40.0K to 50.0K | |
| 27-May-10 8:44 PM View: | Maxygen Inc. (MAXY) | 27-May-10 | Grant | 10,000 | -- | -- | 33% 30.0K to 40.0K | |
| 24-Sep-09 5:44 PM View: | Maxygen Inc. (MAXY) | 22-Sep-09 | Grant | 30,000 | -- | -- | (150%) (-20.0K) to 10.0K | |
| 09-Apr-09 4:05 PM View: | CV Therapeutics, Inc. (CVTX) | 09-Apr-09 | Payment of Exercise | 20,278 | $19.94 | $404,343.00 | (4%) 510.26K to 489.98K | (< 1%) |
| 03-Apr-09 2:14 PM View: | CV Therapeutics, Inc. (CVTX) | 02-Apr-09 | Option Exercise | 641,083 | $12.00 | $7,693,930.00 | 184% 348.35K to 989.43K | 66% |
| 03-Apr-09 2:14 PM View: | CV Therapeutics, Inc. (CVTX) | 02-Apr-09 | Market Option Sale | 479,175 | $19.90 | $9,535,580.00 | (48%) 989.43K to 510.26K | (< 1%) |
| 26-Mar-09 1:07 PM View: | CV Therapeutics, Inc. (CVTX) | 25-Mar-09 | Payment of Exercise | 5,025 | $19.88 | $99,897.00 | (1%) 353.37K to 348.35K | (< 1%) |
| 26-Mar-09 1:07 PM View: | CV Therapeutics, Inc. (CVTX) | 25-Mar-09 | Option Exercise | 11,345 | $19.88 | $225,539.00 | 3% 342.03K to 353.37K | < 1% |
| 26-Feb-09 3:22 PM View: | CV Therapeutics, Inc. (CVTX) | 25-Feb-09 | Payment of Exercise | 22,270 | $15.58 | $346,967.00 | (6%) 364.3K to 342.03K | (28%) |
| 26-Feb-09 3:22 PM View: | CV Therapeutics, Inc. (CVTX) | 25-Feb-09 | Option Exercise | 50,000 | $15.58 | $779,000.00 | 16% 314.3K to 364.3K | 28% |
| 20-Jan-09 3:10 PM View: | CV Therapeutics, Inc. (CVTX) | 15-Jan-09 | Payment of Exercise | 286 | $9.33 | $2,668.38 | (< 1%) 312.28K to 311.99K | (114%) |
| 20-Jan-09 3:10 PM View: | CV Therapeutics, Inc. (CVTX) | 15-Jan-09 | Option Exercise | 801 | $9.33 | $7,473.33 | < 1% 311.48K to 312.28K | 114% |
| 23-Dec-08 4:00 PM View: | CV Therapeutics, Inc. (CVTX) | 22-Dec-08 | Payment of Exercise | 5,026 | $8.91 | $44,781.70 | (2%) 314.82K to 309.8K | (125%) |